Free Trial

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy logo with Medical background

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of U.S. Physical Therapy, Inc. (NYSE:USPH). In a filing disclosed on June 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in U.S. Physical Therapy stock on May 20th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Sold $15,001 - $50,000 in shares of SpringWorks Therapeutics NASDAQ: SWTX on 7/1/2025.
  • Purchased $1,001 - $15,000 in shares of AppLovin NASDAQ: APP on 7/1/2025.
  • Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 6/30/2025.
  • Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 6/30/2025.
  • Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 6/27/2025.
  • Purchased $1,001 - $15,000 in shares of Xiaomi OTCMKTS: XIACF on 6/27/2025.
  • Sold $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 6/27/2025.
  • Sold $1,001 - $15,000 in shares of Willis Towers Watson Public NASDAQ: WTW on 6/26/2025.
  • Sold $1,001 - $15,000 in shares of Boston Scientific NYSE: BSX on 6/26/2025.
  • Sold $1,001 - $15,000 in shares of Liberty Media Corporation - Liberty Formula One Series C NASDAQ: FWONK on 6/26/2025.

U.S. Physical Therapy Price Performance

USPH remained flat at $74.33 during mid-day trading on Friday. 102,649 shares of the company's stock traded hands, compared to its average volume of 137,514. The business's fifty day simple moving average is $76.63 and its two-hundred day simple moving average is $78.16. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. The firm has a market cap of $1.13 billion, a price-to-earnings ratio of 34.10, a price-to-earnings-growth ratio of 3.66 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $101.19.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The company had revenue of $183.79 million for the quarter, compared to analyst estimates of $176.78 million. During the same period last year, the business posted $0.51 earnings per share. The business's revenue for the quarter was up 18.0% compared to the same quarter last year. As a group, research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were issued a $0.45 dividend. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.42%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the business's stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the sale, the director directly owned 2,594 shares of the company's stock, valued at $202,357.94. The trade was a 13.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.00% of the stock is owned by insiders.

Institutional Trading of U.S. Physical Therapy

Several large investors have recently made changes to their positions in the company. Principal Securities Inc. increased its position in U.S. Physical Therapy by 24.7% during the 4th quarter. Principal Securities Inc. now owns 3,293 shares of the company's stock worth $292,000 after purchasing an additional 653 shares in the last quarter. Principal Financial Group Inc. grew its holdings in U.S. Physical Therapy by 4.1% during the 4th quarter. Principal Financial Group Inc. now owns 83,091 shares of the company's stock worth $7,371,000 after acquiring an additional 3,274 shares during the last quarter. AlphaCentric Advisors LLC bought a new stake in U.S. Physical Therapy during the 4th quarter worth approximately $479,000. Truist Financial Corp grew its holdings in U.S. Physical Therapy by 60.1% during the 4th quarter. Truist Financial Corp now owns 17,937 shares of the company's stock worth $1,591,000 after acquiring an additional 6,736 shares during the last quarter. Finally, Venturi Wealth Management LLC grew its holdings in U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after acquiring an additional 704 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on USPH shares. Wall Street Zen upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Barrington Research restated an "outperform" rating and set a $98.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, July 1st. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $109.00.

Read Our Latest Analysis on USPH

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines